ESPE Abstracts (2023) 97 HDI2.2

ESPE2023 How Do I… How Do I… Session 2 (3 abstracts)

How Do I initiate, support, and follow-up people with T1DM on an automated insulin delivery system?

Revital Nimri

Schneider Children's Medical Center of Israel, Petah Tikva, Israel

Automated insulin delivery (AID) systems are increasingly gaining popularity as a viable therapeutic option for managing type 1 diabetes. These systems hold the potential to significantly improve outcomes for individuals with T1D by reducing the risk of hypoglycemia and hyperglycemia, alleviating the burden of diabetes self-management along with improving overall quality of life. Implementation of the technology requires new knowledge for individuals with diabetes as well as health care professionals. In this 'How Do I' session, we will discuss how to guide individuals with diabetes and the healthcare team about the most effective use of AID systems. Clinical insights acquired from various AID studies will be presented, along with the latest recommendations on how to initiate and follow up with individuals starting AID use. Practical clinical recommendations will be presented through case studies. The discussion will include: How do I initiate AID therapy for people with diabetes? general recommendations for initiating AID use such as transitioning from previous different therapies, the optimal time to initiate AID, and setting up the AID system. How do I provide education, training, and support for AID system? AID education should be an integral part of comprehensive diabetes management education. It serves as the peak of the diabetes education pyramid, built upon a strong base of core diabetes knowledge and management, followed by basic education on continuous glucose monitoring (CGM) and pump usage. Essential elements needed for education, training, and follow-up will be reviewed. How do I provide clinical recommendations for AID system? Clinical treatment considerations for AID use will be discussed such as treatment of hypoglycemia events, exercise management, and timing of user-initialed insulin delivery for meals and sick days. Case studies will be presented. How do I report and explain AID data? Understanding AID data information and CGM time in ranges.

Volume 97

61st Annual ESPE (ESPE 2023)

The Hague, Netherlands
21 Sep 2023 - 23 Sep 2023

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.